MENU
+Compare
MET
Stock ticker: NYSE
AS OF
Jan 14, 04:34 PM (EDT)
Price
$78.76
Change
+$1.68 (+2.18%)
Capitalization
50.79B

MET MetLife Forecast, Technical & Fundamental Analysis

MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products... Show more

MET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MET with price predictions
Jan 12, 2026

MET in downward trend: price dove below 50-day moving average on January 12, 2026

MET moved below its 50-day moving average on January 12, 2026 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for MET moved out of overbought territory on December 18, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 44 similar instances where the indicator moved out of overbought territory. In of the 44 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MET as a result. In of 86 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for MET turned negative on December 26, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The 10-day moving average for MET crossed bullishly above the 50-day moving average on December 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MET advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

MET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 284 cases where MET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.755) is normal, around the industry mean (1.649). P/E Ratio (14.516) is within average values for comparable stocks, (14.534). Projected Growth (PEG Ratio) (0.619) is also within normal values, averaging (1.085). Dividend Yield (0.029) settles around the average of (0.038) among similar stocks. P/S Ratio (0.743) is also within normal values, averaging (1.330).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. MET’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
MET
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MET is expected to report earnings to $2.36 per share on February 04

MetLife MET Stock Earnings Reports
Q4'25
Est.
$2.36
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.13
Q1'25
Missed
by $0.08
Q4'24
Est.
$2.09
The last earnings report on November 05 showed earnings per share of $2.34, beating the estimate of $2.31. With 31.39K shares outstanding, the current market capitalization sits at 50.79B.
A.I.Advisor
published Dividends

MET paid dividends on December 09, 2025

MetLife MET Stock Dividends
А dividend of $0.57 per share was paid with a record date of December 09, 2025, and an ex-dividend date of November 04, 2025. Read more...
A.I. Advisor
published General Information

General Information

a provider of insurance and financial services and also function as bank holding company

Industry LifeHealthInsurance

Profile
Fundamentals
Details
Industry
Life Or Health Insurance
Address
200 Park Avenue
Phone
+1 212 578-9500
Employees
45000
Web
https://www.metlife.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
LQDH93.830.23
+0.25%
iShares Interest Rate Hedged Corp Bd ETF
CGCP22.720.02
+0.07%
Capital Group Core Plus Income ETF
SBIO50.86-0.09
-0.18%
ALPS Medical Breakthroughs ETF
TSL18.55-0.09
-0.48%
GraniteShares 1.25x Long Tsla Daily ETF
CORX9.07-0.07
-0.71%
2x Corn ETF

MET and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MET has been closely correlated with PRU. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if MET jumps, then PRU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
-1.58%
PRU - MET
88%
Closely correlated
-0.99%
AFL - MET
86%
Closely correlated
-0.84%
LNC - MET
81%
Closely correlated
-1.60%
JXN - MET
77%
Closely correlated
-2.21%
PRI - MET
76%
Closely correlated
-1.68%
More

Groups containing MET

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MET
1D Price
Change %
MET100%
-1.58%
MET
(11 stocks)
90%
Closely correlated
+0.68%